VIEMED HEALTHCARE, INC.

For the period ended Mar 31, 2026. Filed May 5, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 5, 2026

VMD$8.98+0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Income

VIEMED HEALTHCARE, INC.CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Expressed in thousands of U.S. Dollars, except share and per share amounts)(Unaudited)

	Three Months Ended March 31,
	Note	2026	2025
Revenue	2	$75,414	$59,129
Cost of revenue		32,587	25,850
Gross profit		$42,827	$33,279
Operating expenses
Selling, general and administrative		34,792	28,425
Research and development		579	797
Stock-based compensation	8	2,451	2,311
Depreciation and amortization		388	348
Loss (gain) on disposal of property and equipment		356	(2,368)
Other income, net		(35)	(75)
Income from operations		$4,296	$3,841
Non-operating income and expenses
Interest expense, net	6	305	179
Net income before taxes		3,991	3,662
Provision for income taxes	10	1,278	952
Net income		$2,713	$2,710
Net income attributable to noncontrolling interest		131	85
Net income attributable to Viemed Healthcare, Inc.		$2,582	$2,625
Net income per share
Basic	11	$0.07	$0.07
Diluted	11	$0.06	$0.06
Weighted average number of common shares outstanding:
Basic	11	38,428,588	39,426,753
Diluted	11	40,491,298	41,627,876

See accompanying notes to the condensed consolidated financial statements

Page 4

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.